In this Issue
By Allen C. Ho, MD and Robert L. Avery, MD
BUSINESS OF RETINA
By Maurice B. Landers III, MD; Harry W. Flynn Jr, MD; Mark W. Johnson, MD; H. Culver Boldt, MD; Jan A. Kylstra, MD; J. Niklas Ulrich, MD; Thomasine Gorry, MD; Thomas S. Hwang, MD; Craig Greven, MD; Allan E. Kreiger, MD; and James T. Handa, MD
Preparation for preclinical stages of drug development could have implications for postmarketing success.
By Aron Shapiro; Andy Whitlock, PhD; and Claire Gelfman, PhD
By David C. Reed, MD
A scleral buckle may lead to superior outcomes in high-risk retinal detachments.
By Philip Storey, MD, MPH; and Richard Kaiser, MD
BUSINESS OF RETINA
Maintaining thorough electronic health records may prevent costly audits.
By Riva Lee Asbell
By Omar A. Barrada, MD; Mahmoud M. Soliman, MD; and Ayman M. Khattab, MD
The use of stringent patient selection criteria can help increase resolution rates.
By Arshad M. Khanani, MD
Imaging of eyes implanted with the telescope presents challenges.
By Martha Schlimgen; Melanie J. Fortin, BS, COA; and Brian C. Joondeph, MD, MPS
By Jeffrey Landy, BA; Murat Hasanreisoglu, MD; George Magrath, MD; and Carol L. Shields, MD
SPECIAL REPORT: DIABETIC MICROVASCULAR COMPLICATIONS
A study found no advantage of surgery over intensive medical therapy in diabetic retinopathy development at 2 years.
By Rishi P. Singh, MD
A review of surgical techniques to enhance patients’ visual outcomes after vitrectomy.
By Kourous A. Rezaei, MD
By María H. Berrocal, MD; and David F. Williams, MD, MBA
By Ryan Tarantola, MD; Magdalena Shuler, MD, PhD; Shalesh Kaushal, MD, PhD; Sunil Gupta, MD; and Manish Nagpal, MS, DO, FRCS(UK)
Ivana K. Kim, MD, is an Associate Professor of Ophthalmology at Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston, Massachusetts, and is Co-Director of the Harvard Medical School Department of Ophthalmology AMD Center of Excellence.